{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T05:19:55Z","timestamp":1721971195378},"reference-count":36,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T00:00:00Z","timestamp":1387756800000},"content-version":"vor","delay-in-days":52,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cellular Molecular Medi"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1111\/jcmm.12202","type":"journal-article","created":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T07:44:19Z","timestamp":1387784659000},"page":"1410-1414","source":"Crossref","is-referenced-by-count":4,"title":["Combination therapies in Myeloproliferative Neoplasms: why do we need them and how to identify potential winners?"],"prefix":"10.1111","volume":"17","author":[{"given":"Donal","family":"McLornan","sequence":"first","affiliation":[{"name":"Guy's and St Thomas\u2019 NHS Foundation Trust Guy's Hospital Great Maze Pond London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Harrison","sequence":"additional","affiliation":[{"name":"Guy's and St Thomas\u2019 NHS Foundation Trust Guy's Hospital Great Maze Pond London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,12,23]]},"reference":[{"key":"e_1_2_2_2_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.092155"},{"key":"e_1_2_2_3_1","article-title":"Long\u2010term safety, efficacy, and survival findings from comfort\u2010II, a phase 3 study comparing ruxolitinib with best available therapy (BAT) for the treatment of myelofibrosis (MF)","volume":"120","author":"Cervantes F","year":"2012","journal-title":"ASH Annual Meeting Abstracts"},{"key":"e_1_2_2_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12156"},{"key":"e_1_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12162"},{"key":"e_1_2_2_6_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-2210"},{"key":"e_1_2_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2003.11.003"},{"key":"e_1_2_2_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2405043"},{"key":"e_1_2_2_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-215848"},{"key":"e_1_2_2_10_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.296.5573.1655"},{"key":"e_1_2_2_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrg1879"},{"key":"e_1_2_2_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07870.x"},{"key":"e_1_2_2_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.102"},{"key":"e_1_2_2_14_1","doi-asserted-by":"publisher","DOI":"10.3892\/or.2013.2520"},{"key":"e_1_2_2_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-013-1657-z"},{"key":"e_1_2_2_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403898"},{"key":"e_1_2_2_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/376599a0"},{"key":"e_1_2_2_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1995.tb00103.x"},{"key":"e_1_2_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(06)00122-9"},{"key":"e_1_2_2_20_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5325.567"},{"key":"e_1_2_2_21_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.181181198"},{"key":"e_1_2_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80595-4"},{"key":"e_1_2_2_23_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.50.31515"},{"key":"e_1_2_2_24_1","doi-asserted-by":"crossref","first-page":"2914A","DOI":"10.1182\/blood.V114.22.2914.2914","article-title":"The mTOR inhibitor, RAD001, inhibits the growth of cells from patients with myeloproliferative neoplasms","volume":"114","author":"Vannucchi AM","year":"2009","journal-title":"Blood"},{"key":"e_1_2_2_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(02)00636-6"},{"key":"e_1_2_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2009.01.004"},{"key":"e_1_2_2_27_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1106148"},{"key":"e_1_2_2_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1015"},{"key":"e_1_2_2_29_1","first-page":"38","article-title":"mTOR inhibitors in the treatment of breast cancer","volume":"27","author":"Vinayak S","year":"2013","journal-title":"Oncology (Williston Park)"},{"key":"e_1_2_2_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.17"},{"key":"e_1_2_2_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-007-0733-3"},{"key":"e_1_2_2_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102011\u201001\u2010330563"},{"key":"e_1_2_2_33_1","article-title":"Efficacy of the dual PI3K and mTOR inhibitor NVP\u2010BEZ235 in combination with nilotinib against BCR\u2010ABL\u2010positive leukemia cells involves the ABL kinase domain mutation","volume":"15","author":"Okabe S","year":"2013","journal-title":"Cancer Biol Ther"},{"key":"e_1_2_2_34_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-1102"},{"key":"e_1_2_2_35_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.082560"},{"key":"e_1_2_2_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-478891"},{"key":"e_1_2_2_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-488098"}],"container-title":["Journal of Cellular and Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcmm.12202","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcmm.12202","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcmm.12202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T08:56:53Z","timestamp":1696237013000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcmm.12202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.1111\/jcmm.12202"],"URL":"https:\/\/doi.org\/10.1111\/jcmm.12202","archive":["Portico"],"relation":{},"ISSN":["1582-1838","1582-4934"],"issn-type":[{"value":"1582-1838","type":"print"},{"value":"1582-4934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}